Skip to main content
SpringerLink
Log in

Somatic DNA oxidative damage and coronary disease

  • Clinical Implications
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Andreassi MG, Botto N, Simi S, Casella M, Manfredi S, Lucarelli M, Venneri L, Biagini A, Picano E (2005) Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease. J Mol Med (http://dx.doi.org/10.1007/s00109-005-0634-8)

  2. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214

    Article  CAS  PubMed  Google Scholar 

  3. Collins AR, Gedik CM, Olmedilla B, Southon S, Bellizzi M (1998) Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. FASEB J 12:1397–1400

    Google Scholar 

  4. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM (2001) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106:927–932

    Google Scholar 

  5. Izzotti A, Cartiglia C, Lewtas J, De Flora S (2001) Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J 15:752–757

    Google Scholar 

  6. Offer T, Ho E, Traber MG, Bruno RS, Kuypers FA, Ames BN (2005) A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J (in press)

  7. Andreassi MG, Botto N, Rizza A, Colombo MG, Palmieri C, Berti S, Manfredi S, Masetti S, Clerico A, Biagini A (2002) Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 40:862–868

    Google Scholar 

  8. Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375–429

    Google Scholar 

  9. Shibata A, Kamada N, Masumura KI, Nohmi T, Kobayashi S, Teraoka H, Nakagama H, Sugimura T, Suzuki H, Masutani M (2005) Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent. Oncogene (in press)

  10. Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabo C (2002) Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med 9:659–664

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Franz Volhard Clinic, HELIOS Kliniken Berlin, Medical Faculty of the Charité, Humboldt University, Wiltbergstrasse 50, 13125, Berlin-Buch, Germany

    Friedrich C. Luft

Authors
  1. Friedrich C. Luft
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Friedrich C. Luft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luft, F.C. Somatic DNA oxidative damage and coronary disease. J Mol Med 83, 241–243 (2005). https://doi.org/10.1007/s00109-005-0646-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-005-0646-4

Keywords

Search

Navigation